Nephro-Urology Monthly

Published by: Kowsar

Melanoma Risk in Renal Transplanted Patients

Giovanni Cavaliere 1 , Elisa Zavattaro 2 , Federica Veronese 3 , Paolo Fava 4 and Paola Savoia 3 , *
Authors Information
1 Department of Medical Science, University of Turin, Torino, Italy
2 Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
3 Department of Health Science, University of Eastern Piedmont, Novara, Italy
4 AOU Citta Della Salute e Della Scienza, Torino, Italy
Article information
  • Nephro-Urology Monthly: September 2017, 9 (5); e59535
  • Published Online: July 4, 2017
  • Article Type: Brief Report
  • Received: April 6, 2017
  • Revised: April 21, 2017
  • Accepted: June 10, 2017
  • DOI: 10.5812/numonthly.59535

To Cite: Cavaliere G, Zavattaro E, Veronese F, Fava P, Savoia P. Melanoma Risk in Renal Transplanted Patients, Nephro-Urol Mon. 2017 ; 9(5):e59535. doi: 10.5812/numonthly.59535.

Abstract
Copyright © 2017, Nephro-Urology Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
References
  • 1. Vajdic CM, van Leeuwen MT, Webster AC, McCredie MR, Stewart JH, Chapman JR, et al. Cutaneous melanoma is related to immune suppression in kidney transplant recipients. Cancer Epidemiol Biomarkers Prev. 2009; 18(8): 2297-303[DOI][PubMed]
  • 2. Gallagher MP, Kelly PJ, Jardine M, Perkovic V, Cass A, Craig JC, et al. Long-term cancer risk of immunosuppressive regimens after kidney transplantation. J Am Soc Nephrol. 2010; 21(5): 852-8[DOI][PubMed]
  • 3. Ingvar A, Smedby KE, Lindelof B, Fernberg P, Bellocco R, Tufveson G, et al. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma. Nephrol Dial Transplant. 2010; 25(8): 2764-71[DOI][PubMed]
  • 4. Dean JH, Greene MH, Reimer RR, LeSane FV, McKeen EA, Mulvihill JJ, et al. Immunologic abnormalities in melanoma-prone families. J Natl Cancer Inst. 1979; 63(5): 1139-45[PubMed]
  • 5. Belloni-Fortina A, Piaserico S, Tonin E, Alaibac M. Melanoma and immunosuppression. Dermatology. 2009; 218(1): 88[DOI][PubMed]
  • 6. Green AC, Olsen CM. Increased risk of melanoma in organ transplant recipients: systematic review and meta-analysis of cohort studies. Acta Derm Venereol. 2015; 95(8): 923-7[DOI][PubMed]
  • 7. Einollahi B, Nemati E, Lessan-Pezeshki M, Simforoosh N, Nourbala MH, Rostami Z, et al. Skin cancer after renal transplantation: Results of a multicenter study in Iran. Ann Transplant. 2010; 15(3): 44-50[PubMed]
  • 8. Chatrath H, Berman K, Vuppalanchi R, Slaven J, Kwo P, Tector AJ, et al. De novo malignancy post-liver transplantation: a single center, population controlled study. Clin Transplant. 2013; 27(4): 582-90[DOI][PubMed]
  • 9. Lee CS, Thomas CM, Ng KE. An Overview of the Changing Landscape of Treatment for Advanced Melanoma. Pharmacotherapy. 2017; 37(3): 319-33[DOI][PubMed]
  • 10. Jensen AO, Svaerke C, Farkas D, Pedersen L, Kragballe K, Sorensen HT. Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark. Acta Derm Venereol. 2010; 90(5): 474-9[DOI][PubMed]
  • 11. Lindelof B, Sigurgeirsson B, Gabel H, Stern RS. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol. 2000; 143(3): 513-9[PubMed]
  • 12. Einollahi B, Rostami Z, Nourbala MH, Lessan-Pezeshki M, Simforoosh N, Nemati E, et al. Incidence of malignancy after living kidney transplantation: a multicenter study from iran. J Cancer. 2012; 3: 246-56[DOI][PubMed]
  • 13. Savoia P, Stroppiana E, Cavaliere G, Osella-Abate S, Mezza E, Segoloni GP, et al. Skin cancers and other cutaneous diseases in renal transplant recipients: a single Italian center observational study. Eur J Dermatol. 2011; 21(2): 242-7[DOI][PubMed]
  • 14. Fekecs T, Kadar Z, Battyani Z, Kalmar-Nagy K, Szakaly P, Horvath OP, et al. Incidence of nonmelanoma skin cancer after human organ transplantation: single-center experience in Hungary. Transplant Proc. 2010; 42(6): 2333-5[DOI][PubMed]
  • 15. Keller B, Braathen LR, Marti HP, Hunger RE. Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern. Swiss Med Wkly. 2010; 140[DOI][PubMed]
  • 16. Mackenzie KA, Wells JE, Lynn KL, Simcock JW, Robinson BA, Roake JA, et al. First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients. Nephrol Dial Transplant. 2010; 25(1): 300-6[DOI][PubMed]
  • 17. Bernat Garcia J, Morales Suarez-Varela M, Vilata JJ, Marquina A, Pallardo L, Crespo J. Risk factors for non-melanoma skin cancer in kidney transplant patients in a Spanish population in the Mediterranean region. Acta Derm Venereol. 2013; 93(4): 422-7[DOI][PubMed]
  • 18. Dinh QQ, Chong AH. Melanoma in organ transplant recipients: the old enemy finds a new battleground. Australas J Dermatol. 2007; 48(4): 199-207[DOI][PubMed]
  • 19. Kricker A, Armstrong BK, Goumas C, Litchfield M, Begg CB, Hummer AJ, et al. Ambient UV, personal sun exposure and risk of multiple primary melanomas. Cancer Causes Control. 2007; 18(3): 295-304[DOI][PubMed]
  • 20. Leveque L, Dalac S, Dompmartin A, Louvet S, Euvrard S, Catteau B, et al. [Melanoma in organ transplant patients]. Ann Dermatol Venereol. 2000; 127(2): 160-5[PubMed]
  • 21. Zwald FO, Christenson LJ, Billingsley EM, Zeitouni NC, Ratner D, Bordeaux J, et al. Melanoma in solid organ transplant recipients. Am J Transplant. 2010; 10(5): 1297-304[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments